Press releases

Pharmaceutical study starts in Sweden with BAN2401 in early Alzheimer patients

May 12, 2014 - Other press release

BioArctic Neuroscience AB today announced that the first patient in Sweden has been treated with BAN2401 in a clinical study aimed at patients with an early ...

Pharmaceutical study starts in Sweden with BAN2401 in early Alzheimer patients

Christina Astrén Eriksson

IR and Communications Director

christina.astren@bioarctic.se

+ 46 70 835 43 36

Proud partner of: